RecruitingNCT06089083

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery - PROOF Prospective Cohort Study


Sponsor

University of California, San Francisco

Enrollment

500 participants

Start Date

Oct 18, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Age 18 years or greater
  • Undergoing evaluation for a newly diagnosed gynecologic malignancy
  • Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it

Exclusion Criteria2

  • Contraindication to any study-related procedure or assessment
  • Does not speak a language for which the consent form and study materials are available

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhysical function assessment

Physical assessments of frailty will be conducted in person.

OTHERSelf-reported Assessments and Questionnaires

Quality of life questionnaires and self-reported measures will be provided to complete during the course of the study

PROCEDURESurgery (Standard of Care, Non-Interventional)

Surgical data will be reviewed via medical record


Locations(2)

University of California, San Francisco

San Francisco, California, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06089083


Related Trials